Keyphrases
Gene Therapy
100%
Platelet Function
100%
Wiskott-Aldrich Syndrome
100%
Platelet Phenotype
100%
Lentiviral Gene Therapy
100%
Platelets
42%
X-linked Thrombocytopenia
42%
Untreated Patients
28%
Proteomic Profile
28%
Wiskott-Aldrich Syndrome Protein
28%
Clinical Trials
14%
Protein Expression
14%
Functional Defects
14%
Steady State
14%
Electron Microscopy
14%
Profile Analysis
14%
Ultrastructure
14%
Flow Cytometry
14%
Life-threatening Bleeding
14%
Bleeding Events
14%
Immune Reconstitution
14%
Platelet Count
14%
Thrombocytopenia
14%
Length of Follow-up
14%
Protein Composition
14%
Size Reduction
14%
Platelet Structure
14%
Bleeding Episodes
14%
Platelet Dysfunction
14%
Syndrome X
14%
Therapy Treatment
14%
Aggregation Assay
14%
Platelet Size
14%
Platelet Defects
14%
Microthrombocytopenia
14%
Platelet Proteomics
14%
Medicine and Dentistry
Gene Therapy
100%
Platelet
100%
Wiskott Aldrich Syndrome
100%
Thrombocytopenia
44%
Wiskott Aldrich Syndrome Protein
22%
Proteomics
22%
Flow Cytometry
11%
Clinical Trial
11%
Bleeding
11%
Protein Expression
11%
Morphology
11%
Steady State
11%
Electron Microscopy
11%
Protein Analysis
11%
Ultrastructure
11%
Immune Reconstitution
11%
Syndrome X
11%
Thrombocyte Structure
11%
Thrombocyte Anomaly
11%
Thrombocyte Dysfunction
11%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Platelet
100%
Thrombocytopenia
44%
Wiskott-Aldrich Syndrome Protein
22%
Proteomics
22%
Protein Expression
11%
Steady State
11%
Electron Microscopy
11%
Morphology
11%
Clinical Trial
11%
Platelet Count
11%
Agonist
11%
Immune Reconstitution
11%
Thrombocyte Structure
11%
Flow Cytometry
11%
Immunology and Microbiology
Platelet
100%
Wiskott-Aldrich Syndrome
100%
Proteomics
22%
Electron Microscopy
11%
Morphology
11%
Immune Reconstitution
11%
Protein Expression
11%
Platelet Count
11%
Agonist
11%
Steady State
11%
Thrombocyte Structure
11%